
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
PetMed Express is a pharmaceutical retailers business based in the US. PetMed Express shares (PETS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.25 – a decrease of 20.11% over the previous week. PetMed Express employs 287 staff and has a trailing 12-month revenue of around $247 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $4.25 |
---|---|
52-week range | $2.90 - $6.85 |
50-day moving average | $5.11 |
200-day moving average | $4.26 |
Wall St. target price | $3.75 |
PE ratio | 425 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.01 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.47 from 2025-02-13
1 week (2025-02-07) | -15.98% |
---|---|
1 month (2025-01-15) | -12.52% |
3 months (2024-11-15) | -4.89% |
6 months (2024-08-15) | 41.90% |
1 year (2024-02-14) | -15.34% |
---|---|
2 years (2023-02-14) | -76.20% |
3 years (2022-02-14) | 23.3364 |
5 years (2020-02-14) | 23.2369 |
Valuing PetMed Express stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetMed Express's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PetMed Express's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 425x. In other words, PetMed Express shares trade at around 425x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PetMed Express's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetMed Express's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PetMed Express's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.2 million.
The EBITDA is a measure of a PetMed Express's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $247 million |
---|---|
Gross profit TTM | $68.4 million |
Return on assets TTM | 0.93% |
Return on equity TTM | 0.36% |
Profit margin | 0.15% |
Book value | $4.66 |
Market Capitalization | $92.3 million |
TTM: trailing 12 months
We're not expecting PetMed Express to pay a dividend over the next 12 months.
PetMed Express's shares were split on a 959692:319 basis on 3 March 1999 . So if you had owned 319 shares the day before before the split, the next day you'd have owned 959692 shares. This wouldn't directly have changed the overall worth of your PetMed Express shares – just the quantity. However, indirectly, the new 100% lower share price could have impacted the market appetite for PetMed Express shares which in turn could have impacted PetMed Express's share price.
Over the last 12 months, PetMed Express's shares have ranged in value from as little as $2.9 up to $6.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetMed Express's is 0.696. This would suggest that PetMed Express's shares are less volatile than average (for this exchange).
PetMed Express, Inc. , together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Spot dogecoin ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.